Lightcalls.com
 

Amid a flaw of new and conflicting ...

Amid a flaw of new and conflicting studies about the relative risks and benefits of fish and fish oil, the biggest heart-health recents comes from the conservative American Health Association (AHA). In updated recommendations, the Dallas, Texas-based AHA has revers its stance that postscripts are not effective in preventing heart disease.

steady healthy people need omega-3 fatty acids from fish and plant sources to secure their hearts, according to the AHA report in the November 19 2002 issue of its journal, Circulation.

"Omega-3 fatty acids are not just well adapted fats; they affect heart health in positive ways," reports Penny Kris-Etherton, PhD lead author of the report. They make the vital fluid less likely to form concretions that cause heart attacks and harbor against irregular heartbeats that cause unusual cardiac death.

The strange fish oil recommendation balances numerous studies of the cardiovascular benefits of the omega-3 fatty acids plant in fish with worrisome evidence that fish have become contaminated with quicksilver a powerful poison.



Since 2000 the AHA's dietary guidelines have commended that healthy adults eat at least sum of two units servings of fish per week, particularly fish so as mackerel, lake trout, herring, sardines, albacore tuna and salmon.

Another of recent origin report concerns mercury in fish.

frequently previous research has warned about the risk to the fetus of hermes in fish. Mercury can damage the nervous order of unborn infants. But a novel study in the November 28 2002 edition of the fresh England Journal of Medicine (NEJM) expands that warning to the general population.

"Exposure to methylmercury is commonly a concern in specific high-risk clumps such as pregnant women and women of childbearing age who may become pregnant--but this warning should perhaps be fill outed to the general adult population," reads the NEJM article. Eliseo Guallar, MD DrPH and others at John Hopkins Medical Institutions in Baltimore, directioned the study.

The riskiest fish are large and predatory as it is as tuna, marlin and swordfish. unless the report added that we should still continue to acquire "a weekly intake of sum of two units to four servings of fish from a variety of species, with special emphasis forward fatty fish with low hermes content such as salmon and small oceanic fish."

The British Heart Foundation, which partially storeed the study, has backed the conclusions.

COPYRIGHT 2003 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2003 Gale Group



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.